Sepsis drug dosing study aims to boost survival
NCT ID NCT07245966
First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 21 times
Summary
This study looked at how high doses of the antibiotic ceftriaxone work in 20 adults with sepsis. The goal was to find the best dose to keep drug levels high enough to kill bacteria. Researchers used blood samples and computer models to see if the dose reached the target. The study did not test a new treatment but aimed to improve how this common antibiotic is used.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, 90110, Thailand
Conditions
Explore the condition pages connected to this study.